REMARK, NCT04462614: Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN â„¢ Membrane and Treated by Long-term Anticoagulation With VKA |
|
|
| Not yet recruiting | N/A | 49 | Europe | Decrease per-dialytic heparin therapy | CHU de Reims | Chronic Hemolysis, VKA, Anticoagulants / Administration & Dosage, Coated Materials, Biocompatible, Heparin / Administration & Dosage, Membranes Artificial, Prospective Studies, Renal Dialysis / Methods, Renal Insufficiency / Therapy | 01/21 | 07/21 | | |
